General Information
DRAVP ID DRAVPe01650
Peptide Name Peptide 15(lactoferrin 422-425)
Sequence SLDC
Sequence Length 4
UniProt ID P24627
Source Synthetic construct
Activity Information
Target Organism Influenza virus
Assay Neutralization assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity No cytotoxicity information found in the reference(s) presented
Binding Target hemagglutinin (HA)
Mechanism Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes.
Structure Information
PDB ID 3IB0
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Acylation
C-terminal Modification Amidation
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C16H28N4O8S
Absent amino acids AEFGHIKMNPQRTVWY
Common amino acids CDLS
Mass 436.48
Pl 3.8
Basic residues 0
Acidic residues 1
Hydrophobic residues 1
Net charge -1
Boman Index -592
Hydrophobicity 50
Aliphatic Index 97.5
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Literature Information
Literature 1
Title Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.
Pubmed ID 28878220
Reference Sci Rep. 2017 Sep 6;7(1):10593.
Author Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.
DOI 10.1038/s41598-017-10492-x
Literature 2
Title Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies.
Pubmed ID 34681184
Reference Pharmaceuticals (Basel). 2021 Sep 23;14(10):959.
Author Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M.